Pharmafile Logo

Case study: How segmentation of treaters guided a novel product launch in the allergy space

July 17, 2023 | Medtech, Segmentation, allergy 

Find out how we helped our client to obtain an intuitive and actionable segmentation in order to drive market shaping activities ahead of their product launch aimed at the treatment of Serious Allergic Reactions.

Our client developed a novel product for  the treatment of Serious Allergic Reactions (SAR) and wanted to obtain an intuitive and actionable segmentation of treaters in this space, in order to form a market understanding.

Research was therefore required to drive market shaping activities ahead of the launch of Product X.

Read the full case study here:  https://bit.ly/44FYmbM

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market

From chaos to calm: how to make sense of social media

What do you know about chaos theory?

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

Infographic: HCV LATAM

An introduction to the HCV LATAM patient.

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard